 |
AAPS J
- LONG M, Peng Y, Gade S, Nicholson H, et al
Innovative In Vitro-In Silico Platform for Dose-Response Modeling in Canine
Bladder Cancer: A 3D Organoid- and Mathematics-Based Approach.
AAPS J. 2026;28:74.
PubMed
Abstract available
ACS Appl Bio Mater
- RIBEIRO CPS, Fernandes R, Lourenco LMO
Smart Macrocycles: Cyclodextrin-Porphyrin Photosensitizers for Photodynamic
Therapy in Human Bladder Cancer Cells.
ACS Appl Bio Mater. 2026 Mar 18:XXX. doi: 10.1021/acsabm.6c00053.
PubMed
Abstract available
Actas Urol Esp (Engl Ed)
- CANO-VELASCO J, Luis-Cardo A, Moreno-Cortes JC, Carrasco-Loras L, et al
Impact of Intravesical BCG Therapy on Quality of Life in Non-Muscle-Invasive
Bladder Cancer: A Prospective Evaluation Using The FACT-Bl Questionnaire.
Actas Urol Esp (Engl Ed). 2026 Mar 16:501937. doi: 10.1016/j.acuroe.2026.501937.
PubMed
Abstract available
- FELTES BENITEZ N, Counago F, Paredes-Rubio S, Peleteiro Higuero P, et al
Prognostic Factors and Oncological Outcomes after Trimodality Bladder-Preserving
Therapy for Muscle-Invasive Bladder Cancer: A Multicenter Real-World Study.
Actas Urol Esp (Engl Ed). 2026 Mar 16:501967. doi: 10.1016/j.acuroe.2026.501967.
PubMed
Abstract available
Adv Sci (Weinh)
- XU X, Liang R, Zhao A, Zhang J, et al
Ferroptosis Induction by Fenbendazole Combined With Photothermal Therapy Triggers
Dual-Immunotherapy Against Bladder Cancer.
Adv Sci (Weinh). 2026 Mar 20:e74876. doi: 10.1002/advs.74876.
PubMed
Abstract available
Am Soc Clin Oncol Educ Book
- LI J, Ballas L, Ghatalia P
Bladder Preservation Strategies in Muscle-Invasive Bladder Cancer.
Am Soc Clin Oncol Educ Book. 2026;46:e515984.
PubMed
Abstract available
Ann Nucl Med
- SABER TANHA A, Sadeghi R, Ghorbani H, Soltani S, et al
Lymphatic mapping and sentinel lymph node biopsy in urinary bladder cancer: A
SPECT/CT-based experience.
Ann Nucl Med. 2026 Mar 13. doi: 10.1007/s12149-026-02181.
PubMed
Abstract available
Ann Surg Oncol
- SLUSARCZYK A, Moschini M, Krajewski W, Scilipoti P, et al
Bladder Tumor Location Matters: Trigone and Bladder Neck Involvement Predict
Worse Oncological Outcomes in High-Grade Non-Muscle-Invasive Bladder Cancer.
Ann Surg Oncol. 2026 Mar 20. doi: 10.1245/s10434-026-19476.
PubMed
Abstract available
Biochem Pharmacol
- CHENG H, Lu L, Gong Y, Liu S, et al
Targeting EGFR with sanguinarine chloride: a novel approach to bladder cancer
therapy.
Biochem Pharmacol. 2026 Mar 16:117905. doi: 10.1016/j.bcp.2026.117905.
PubMed
Abstract available
BJU Int
- ROESSLER N, Miszczyk M, Gontero P, Dematteis A, et al
Clinical complete response as a surrogate for pathological response in bladder
cancer: a systematic review and meta-analysis.
BJU Int. 2026 Mar 16. doi: 10.1111/bju.70214.
PubMed
Abstract available
- SATHIANATHEN N, Perera M, Ischia J, Lawrentschuk N, et al
Use of MRI in the diagnosis of bladder cancer: a health economic analysis.
BJU Int. 2026 Mar 18. doi: 10.1111/bju.70243.
PubMed
-
Correction to "Long-term multicentre analysis of robot-assisted radical
cystectomy for non-muscle-invasive bladder cancer".
BJU Int. 2026 Mar 19. doi: 10.1111/bju.70248.
PubMed
- SLUSARCZYK A, Scilipoti P, Contieri R, Krajewski W, et al
Refining BCG-failure classifications in non-muscle-invasive bladder cancer.
BJU Int. 2026 Mar 19. doi: 10.1111/bju.70231.
PubMed
Abstract available
BMC Cancer
- FEKNER Z, Sieracka J, Dabrowski P, Kazmierski L, et al
Mumio and bladder cancer: unlocking its potential in 3D cell culture.
BMC Cancer. 2026 Mar 14. doi: 10.1186/s12885-026-15838.
PubMed
Cancer Epidemiol
- VANEGAS CARDENAS SA, Cantor EJ, de Vries E
Incidence, mortality, and five-year survival of bladder cancer in six
population-based cancer registries in Colombia, 2003-2018.
Cancer Epidemiol. 2026;102:103049.
PubMed
Abstract available
Cancer Manag Res
- MAHDIPOUR S, Modarressi MH, Noruzinia M
Methylation and Expression Analysis of POU4F2, HOXA9, RBM46, and TSGA10 Genes in
Bladder Cancer Using Methyl-Sensitive Restriction Enzyme PCR (MSRE-PCR).
Cancer Manag Res. 2026;18:557943.
PubMed
Abstract available
Cancer Med
- HU X, Miao J, Huang Y, Yang Y, et al
Urinary Diversion-Specific Morbidity After Radical Cystectomy: A Ten-Year
Institutional Experience.
Cancer Med. 2026;15:e71684.
PubMed
Abstract available
Cancer Rep (Hoboken)
- DOUMANIDIS P, Tsagkozis P
Surgical Management of Bone Metastases in Bladder Cancer: A Single-Center
Retrospective Study.
Cancer Rep (Hoboken). 2026;9:e70524.
PubMed
Abstract available
Cancer Treat Res Commun
- PORRECA A, Marino F, De Marchi D, Giampaoli M, et al
Can we define the clinical variables predicting T0 after neoadjuvant systemic
therapy in bladder cancer?
Cancer Treat Res Commun. 2026;47:101181.
PubMed
Abstract available
Cancers (Basel)
- VENKATESH A, Rodriguez Rosales RD, Kanumuambidi JP, Ishiyama Y, et al
Role of Spatial Heterogeneity in Muscle-Invasive Bladder Cancer on Overall
Survival and Immunotherapy Response.
Cancers (Basel). 2026;18:875.
PubMed
Abstract available
- KIM T, Shin D, Ahn HK, Moon YJ, et al
Urine-Based cfDNA Ensemble Modeling for Early Detection of Bladder Cancer Using
Whole-Genome Methylation Sequencing.
Cancers (Basel). 2026;18:767.
PubMed
Abstract available
Cell Biol Toxicol
- LIU Y, Tang A, Wang H
Toxicogenomic Characterization of Perfluorooctanoic Acid-Associated Bladder
Carcinogenesis.
Cell Biol Toxicol. 2026;42:47.
PubMed
Abstract available
Cell Oncol (Dordr)
- HU Z, Jiang N, Xie B, Zhou J, et al
CircBARD1 suppresses tumor progression driven by H3K18 lactylation-CCNA2 axis in
human bladder cancer.
Cell Oncol (Dordr). 2026;49:58.
PubMed
Cell Signal
- ZHANG L, Chen C, Huang W, Dong L, et al
PIN1 suppresses bladder cancer progression by inducing cellular senescence and
activating the interferon response pathway.
Cell Signal. 2026;143:112476.
PubMed
Abstract available
Clin Genitourin Cancer
- ZHU J, Ma X, Xie F, Wang Y, et al
TNM Stage-Stratified Comparison Between Urachal and Nonurachal Adenocarcinomas of
the Bladder: A Single-Center Retrospective Cohort Study.
Clin Genitourin Cancer. 2026;24:102509.
PubMed
Abstract available
- ASLANOVA M, Pereanu W, Lawrence A, Wang H, et al
Tumor-Informed Circulating Tumor DNA (ctDNA) in Locally Advanced and Metastatic
Urothelial Carcinoma: A Retrospective Single-Center Cohort.
Clin Genitourin Cancer. 2026;24:102512.
PubMed
Abstract available
- PARIKH M, McMahon P, Eng S, Boateng F, et al
Retrospective, Observational Analysis of Real-World Safety Outcomes in Patients
With Locally Advanced/Metastatic Urothelial Cancer Treated With Sacituzumab
Govitecan.
Clin Genitourin Cancer. 2026;24:102516.
PubMed
Abstract available
Crit Rev Oncol Hematol
- ZHAO K, Zhou Z, Ma X, Xiao X, et al
Progress and challenges in CAR-T cell therapy for bladder cancer.
Crit Rev Oncol Hematol. 2026;222:105275.
PubMed
Abstract available
- TANG Y, Wang L, Liu H, Zhu Q, et al
Advances in intravesical therapy for non-muscle-invasive bladder cancer.
Crit Rev Oncol Hematol. 2026;222:105271.
PubMed
Abstract available
Cureus
- BOUNOUAR O, El Moudane A, Andrea E, Jdaini A, et al
Urothelial Bladder Cancer With Cardiac Metastasis: A Case Report.
Cureus. 2026;18:e103414.
PubMed
Abstract available
- LEASK J, Ibrahim I, Wilson B, Hendry J, et al
The Role of Socioeconomic Status in Influencing Stage at Presentation and Overall
Survival in Bladder Cancer: Experience From the West of Scotland.
Cureus. 2026;18:e103399.
PubMed
Abstract available
Environ Pollut
- JIE J, Wang Q, Chen Z, Hu C, et al
Multi-omics analysis and preliminary experimental validation of acetyl tributyl
citrate (ATBC) promoting bladder cancer progression via the AKR1B1/EMT axis.
Environ Pollut. 2026;397:127970.
PubMed
Abstract available
Eur Urol Oncol
- DUQUESNE I, Epelbaum I, Prost D, Haberstich M, et al
Blood and Urine Circulating Tumor DNA in Urothelial Bladder Cancer: State of the
Art and Clinical Perspective.
Eur Urol Oncol. 2026 Mar 19:S2588-9311(26)00065.
PubMed
Abstract available
Exp Mol Pathol
- SAKATANI T, Tanaka S, Murakami K, Jinno C, et al
Development and validation of a tumor-derived CXCL1 qPCR assay to support patient
selection for anti-CXCL1 therapeutics in bladder cancer.
Exp Mol Pathol. 2026;146:105039.
PubMed
Abstract available
- LOMBARDO KA, Yoshida T, Johnson E, Fitzgerald K, et al
Molecular characterization of non-muscle invasive tumor from
N-methyl-N-nitrosourea (MNU)-induced urothelial carcinoma in a rat model reveals
hallmarks of both luminal and basal subtypes.
Exp Mol Pathol. 2026;145:105032.
PubMed
Abstract available
Front Cell Dev Biol
- YU H, Lei Q, Yang W, Cao M, et al
FAM-related prognostic molecular subtype screening identified epithelial-derived
MAOA-inhibiting bladder cancer.
Front Cell Dev Biol. 2026;14:1732999.
PubMed
Abstract available
Front Oncol
- SUN L, Liu C, Yuan L
Evolving patterns of bladder cancer mortality in US adults: a two-decade analysis
reveals persistent disparities despite overall progress (1999-2020).
Front Oncol. 2026;16:1713506.
PubMed
Abstract available
- HE J, Liu X, Li S, Xia Z, et al
A systematic characterization of amino acid metabolism-related genes reveals
molecular subtypes and a prognostic signature in bladder cancer.
Front Oncol. 2026;16:1754912.
PubMed
Abstract available
- WU Q, Zhou Y, Ou Z, Fu H, et al
Peroxisomal activity drives aggressive bladder cancer phenotypes and reveals
erythorbic acid as a potential therapeutic modulator.
Front Oncol. 2026;16:1734437.
PubMed
Abstract available
Int J Med Inform
- HJORT PB, Jensen JE, Jensen JB, Ernst A, et al
Study of bladder cancer detection in standard white light versus AI-supported
endoscopy-01 (RAISE-01) - Development and validation of an AI-based support tool.
Int J Med Inform. 2026;213:106390.
PubMed
Abstract available
Int J Mol Sci
- DOMIAN N, Smereczanska M, Mrugacz M, Mlynarczyk G, et al
Comparative Evaluation of HMG Family Proteins and miR-106a-5p in Low-Grade
Non-Invasive and High-Grade Muscle-Invasive Papillary Urothelial Carcinoma.
Int J Mol Sci. 2026;27:2089.
PubMed
Abstract available
- PARRAO D, Gallegos H, Ruz K, Lay R, et al
Use of Artificial Intelligence Model Associated with Masson's Trichrome Staining
as a Predictor of Muscle Invasion in Bladder Cancer.
Int J Mol Sci. 2026;27:2237.
PubMed
Abstract available
Int J Urol
- GOTO Y
Editorial Comment on Comparison of Perioperative Chemotherapy Regimens for
Muscle-Invasive Bladder Cancer: A Reconstructed Individual Patient Data Analysis
of Phase 3 Trials.
Int J Urol. 2026;33:e70405.
PubMed
Int Urol Nephrol
- TANG C, Wang T, Luo H, Xue J, et al
Liquid biopsy based on multi-targeted capture of urinary tumor DNA combined with
machine learning to detect urothelial carcinoma: a multicenter prospective study.
Int Urol Nephrol. 2026;58:1291-1306.
PubMed
Abstract available
- SRIVASTAVA A, Trivedi S, Singh Y, Kumar U, et al
Prospective comparative evaluation of clinical efficacy and safety of
Intravesical gemcitabine-docetaxel versus BCG in adjuvant management of BCG-naive
non-muscle invasive urothelial bladder cancer in Indian population.
Int Urol Nephrol. 2026 Mar 17. doi: 10.1007/s11255-026-05067.
PubMed
Abstract available
J Bioenerg Biomembr
- WANG Y, Zhang A, Che H, Gao J, et al
Coenzyme Q10 exerts anti-cancer effects in bladder cancer by inducing
ROS-mediated apoptosis and autophagy.
J Bioenerg Biomembr. 2026 Mar 19. doi: 10.1007/s10863-026-10093.
PubMed
J Clin Med
- MELGAREJO SEGURA MT, Herraez Marcos M, Cano Garcia MC, Zambudio Munuera A, et al
De-Intensification Strategies in Non-Muscle-Invasive Bladder Cancer: Outcomes and
Cost Impact of In-Office Bladder Fulguration.
J Clin Med. 2026;15:1939.
PubMed
Abstract available
J Control Release
- HUANG L, Sun X, Song T, Liu Z, et al
Squid tentacle-mimetic magnetically targeted nanomotors to overcome the bladder
barrier for synergistic chemotherapy-immunotherapy of bladder cancer.
J Control Release. 2026;393:114808.
PubMed
Abstract available
J Geriatr Oncol
- BAHAR P, Perez-Londono A, Kaul S, Efstathiou J, et al
Population-based outcomes of chemoradiation therapy for muscle-invasive bladder
cancer in older adults.
J Geriatr Oncol. 2026;17:102939.
PubMed
Abstract available
J Surg Case Rep
- ALWABEL W, Almisfer A, Alsamaani I, Aljaafri B, et al
Intravesical therapy for bladder cancer causing disseminated tuberculosis and
perforated viscus: a case report.
J Surg Case Rep. 2026;2026:rjag131.
PubMed
Abstract available
J Urol
- BEN-DAVID R, Raizenne BL, Eraky A, Duquesne I, et al
Preoperative ctDNA Predicts Upstaging and Recurrence in High-Risk Non-Muscle
Invasive Bladder Cancer Undergoing Radical Cystectomy.
J Urol. 2026 Mar 17:101097JU0000000000005034. doi: 10.1097/JU.0000000000005034.
PubMed
Abstract available
J Vet Med Sci
- KOMORI M, Ogawa M, Yonezawa T, Momoi Y, et al
Significance of monocyte-to-lymphocyte ratio as a prognostic factor in canine
urothelial carcinoma: a retrospective study.
J Vet Med Sci. 2026;88:485-491.
PubMed
Abstract available
Lancet Prim Care
- MAHATI SG, Wu J, Walter FM, Zhou Y, et al
Defining recurrent urinary tract infections and quantifying bladder cancer risk
in primary care in England: a nationwide case-control study.
Lancet Prim Care. 2026;2:None.
PubMed
Abstract available
Magn Reson Med Sci
- WATANABE H, Takeuchi M, Higaki A, Kojima Y, et al
Histopathological Basis of Peritumoral Enhancement in Muscle-invasive Bladder
Cancer.
Magn Reson Med Sci. 2026 Mar 19. doi: 10.2463/mrms.mp.2025-0211.
PubMed
Abstract available
Medicine (Baltimore)
- BAI J
Impact of physiological ability and surgical stress score on postoperative
complications in patients undergoing surgery for non-muscle-invasive bladder
cancer.
Medicine (Baltimore). 2026;105:e47699.
PubMed
Abstract available
Neurourol Urodyn
- GERSHMAN B, Perez-Londono A, Almohtasib J, Kaul S, et al
Voiding Dysfunction Among Older Adults With Non-Muscle Invasive Bladder Cancer:
Incidence and Predictors of Treatment for Overactive Bladder.
Neurourol Urodyn. 2026 Mar 19. doi: 10.1002/nau.70269.
PubMed
Abstract available
Pathol Oncol Res
- VARADI M, Magyar B, Szeles A, Korda S, et al
Prognostic and predictive factors of immune checkpoint inhibitor therapy in
urinary bladder cancer.
Pathol Oncol Res. 2026;32:1612333.
PubMed
Abstract available
Pediatr Transplant
- ICHAS M, Allard L, Harper L, Yacoub M, et al
Urothelial Carcinoma of the Bladder Following BK Virus Infection in a Pediatric
Kidney Transplant Recipient.
Pediatr Transplant. 2026;30:e70303.
PubMed
Abstract available
Prague Med Rep
- TURAN S, Gezmis CT, Israfilov A, Aydin M, et al
Primary Mucinous Bladder Adenocarcinoma.
Prague Med Rep. 2026;127:44-47.
PubMed
Abstract available
Q J Nucl Med Mol Imaging
- GUGLIELMO P, Perrone E, Librando M, Aghaee A, et al
Novel radiopharmaceuticals for bladder cancer evaluation.
Q J Nucl Med Mol Imaging. 2026 Mar 19. doi: 10.23736/S1824-4785.26.03706.
PubMed
Abstract available
- EVANGELISTA L, Guglielmo P
From prostate to bladder cancer: current evidence and expanding horizons in
nuclear medicine.
Q J Nucl Med Mol Imaging. 2026 Mar 19. doi: 10.23736/S1824-4785.26.03731.
PubMed
Rev Esp Enferm Dig
- BAS-CUTRINA F, Morales-Alvarado VJ, Gomis-Marti M, Jimenez-Serrano E, et al
Endoscopic vacuum therapy for leaky cavities: is it possible?
Rev Esp Enferm Dig. 2026;118:112-114.
PubMed
Abstract available
Sci Rep
- ZHANG C, Cao S, Zeng G, Dong Y, et al
APR-246 drives ROS-dependent ferroptosis and apoptosis and enhances anti-PD-1
efficacy in bladder cancer.
Sci Rep. 2026 Mar 15. doi: 10.1038/s41598-026-44653.
PubMed
Semin Diagn Pathol
- WU DJ, Chan E
Histologic mimics of urothelial carcinoma.
Semin Diagn Pathol. 2026;43:150993.
PubMed
Abstract available
Small
- YAO W, Shen W, Zhou H, Dai X, et al
Bioinspired IgM-Mimetic Polyvalent Aptamer-Albumin Nanoplatform for Targeted
Intravesical Therapy of Bladder Cancer.
Small. 2026 Mar 19:e14393. doi: 10.1002/smll.202514393.
PubMed
Abstract available
Strahlenther Onkol
- DUNST J
[Cystectomy plus perioperative enfortumab vedotin/pembrolizumab in bladder
cancer].
Strahlenther Onkol. 2026;202:448-450.
PubMed
Tissue Cell
- KOLAHI AZAR H, Beheshtizadeh N, Rezapour R, Pourlak T, et al
p16 positivity as a potent indicator of high-grade histology and its interplay
with HER2/neu in urothelial bladder carcinoma.
Tissue Cell. 2026;100:103390.
PubMed
Abstract available
Urol Oncol
- PEARSON M, Engen PA, Green SJ, Emerson J, et al
Microbial profiling of urothelial carcinoma and benign bladder tissue from
formalin-fixed specimens.
Urol Oncol. 2026;44:110997.
PubMed
Abstract available
- BRACARDA S, Mammone G, Mosillo C, Sirgiovanni G, et al
Circulating tumor DNA in urothelial cancer as an intermediate disease state
between localized and advanced stages: Moving from risk factors to
micrometastatic disease in the perioperative setting.
Urol Oncol. 2026;44:110986.
PubMed
Abstract available
- MARDELLI C, Bertail T, Tachibana I, Verhoest G, et al
Refining prognostication in non-muscle-invasive bladder cancer: From clinical
models to artificial intelligence.
Urol Oncol. 2026 Mar 13:111047. doi: 10.1016/j.urolonc.2026.111047.
PubMed
Abstract available
Urol Pract
- ASSEL M, Vickers AJ
Letter: Incarcerated Patients Present With More Advanced Bladder Cancer Stage: A
Statewide Analysis.
Urol Pract. 2026 Mar 16:101097UPJ0000000000000987.
PubMed
Urology
- SMELSER WW
Editorial Commentary: "Treatment Selection for Non-Muscle-Invasive Bladder Cancer
in an Emerging Treatment Era: A Patient Preference Study.
Urology. 2026 Mar 17:S0090-4295(26)00177-9. doi: 10.1016/j.urology.2026.
PubMed
World J Urol
- KITANO H, Watanabe E, Tadera K, Nakano Y, et al
Urine culture-guided antibiotic prophylaxis reduces febrile pyelonephritis after
ureteral stent removal following radical cystectomy.
World J Urol. 2026;44:249.
PubMed
Abstract available
FAQ
